Fingerprint
Dive into the research topics of 'Long-term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2-year results from two pivotal phase 3 studies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically